RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy
In conclusion, these results indicated that the RVG29-modified NPs have potential efficacy for glioma therapy. Graphical abstract
Source: International Journal of Pharmaceutics - Category: Drugs & Pharmacology Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Chemotherapy | Docetaxel | Drugs & Pharmacology | Glioma | Men | Nanotechnology | Neurology | Polyethylene Glycol | Study | Taxotere | Toxicology